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Plan Employer Data and Information Set (HEDIS) deﬁnitions, as
well as among the classes of asthma medications. METHODS:
A retrospective cohort analysis of the Integrated Health care
Information Services (IHCIS) administrative database evaluated
patients >/= 5 years of age with at least 2 prescriptions of asthma
medication. Asthma severity was classiﬁed as HP (n = 21,698)
or HNP (n = 11,967), in accordance with 2006 HEDIS criteria;
compliance, calculated as medication possession ratios (MPR)
and persistence, calculated as days supply before discontinua-
tion, switching, or augmentation, were measured in patients
treated with inhaled corticosteroids (ICS) (n = 3906 HP, n = 3856
HNP), leukotriene modiﬁers (LM) (n = 10,005 HP, n = 3823
HNP), and ICS + LABA combinations (n = 5893 HP, n =
3538 HNP) over a 1-year period. The study groups’ comparisons
were conducted using t-test or analysis of variance where appro-
priate. RESULTS: Overall, HP patients had higher MPRs with
all categories of medication (71 + 29%) compared with HNP
patients (43 + 27%, p < 0.001). Oral LM (78 + 27% HP, 51 +
29% HNP) were taken more frequently than ICS (55 + 30% HP,
31 + 21% HNP) or ICS + LABA combinations (65 + 28% HP,
p < 0.001, 43 + 25% HNP, p < 0.001). Persistence was longer
for LM (139 + 110 days HP, 90 + 86 days HNP), than for ICS
(64 + 72 days HP, 37 + 32 days HNP), or ICS + LABA (106 +
108 days HP, 66 + 73 days HNP, p < 0.001 for both). CON-
CLUSION: Both compliance and persistence remained subopti-
mal in this large asthmatic population, with HNP patients far
less consistent with their medication dosing and duration of use
than HP patients. LMs were used more consistently than inhaled
medications, with ICS being the least consistently used asthma
medication. Additional measures are needed to improve compli-
ance and persistence with these medications.
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OBJECTIVES: Pay-for-performance is gaining popularity and
acceptance as an approach to improve quality and efﬁciency of
health care in the U.S. However, little evidence regarding the eco-
nomic feasibility of this approach is currently available in the 
literature. Our objective was to examine the cost savings of 
a quality-based physician incentive program implemented in a
PPO setting. METHODS: Administrative claims data for
2003–2005 were obtained from a voluntary physician incentive
program implemented by a large non-proﬁt health plan in
Hawaii and used to calculate all costs and probabilities included
in the decision tree. Health plan members were categorized into
two groups: those who visited only physicians who participated
in the program and those who visited only non-participating
physicians during the study period. Rates of recommended care
for two evidence-based quality of care indicators—glycosylated
hemoglobin testing and lipid panel testing for members with dia-
betes—were compared between the two groups to determine
program effectiveness. Program costs included administrative
costs, the cost of quality of care evaluation, and physician reim-
bursement. Quality indicators that included several procedures
were assigned a weighted average cost. One year events included
severe diabetic complications. RESULTS: Average program cost
per enrollee was $21; the average cost of receiving the two tests
was $18; and the cost of developing relevant complications was
$6470. With the incentive program, the health plan saved
approximately $18 per adult diabetic considering just the two
indicators (i.e., total program costs were distributed across just
the two indicators for the purposes of this analysis), which trans-
lated to two year savings ranging from $2.5 to $6.7 million.
CONCLUSION: Physician reimbursement models built upon
evidence-based quality of care metrics may result in direct cost
savings to the health plan within a relatively short follow-up
time, in addition to positively affecting delivery of high quality,
recommended care.
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OBJECTIVES: To investigate the impact of a multidisciplinary
disease management program implemented in 3 different hospi-
tals on the functional status, quality of life, and utilization of
hospital resources for patients with congestive heart failure
(CHF). The study also examined the ﬁnancial outcomes of the
program. METHODS: We evaluated the program by comparing
the rates of readmission (CHF) within 3- and 12-month of initial
discharge, the cumulative number of hospital days, the rate of
ED visits and ﬁnancial outcomes within 12 months of enrolment
for 431 patients given a multidisciplinary disease management
intervention against 141 patients who received usual care.
Changes in functional outcomes of patients on the program were
assessed at baseline and at six months using the 6-minute walk
distance and the New York Heart Association (NYHA) Func-
tional Classiﬁcation. The Minnesota Living with Heart Failure
Questionnaire was used to measure patients’ quality of life.
RESULTS: The intervention group had considerably and signif-
icantly lower hospital readmission rates than the control group
(5.6% vs. 15.6% within 3 months, P = 0.001, 13.2% vs. 29.8%
within 12 months, P < 0.001). The mean hospital days per
patient was also reduced from 3.3 ± 11.2 to 1.0 ± 3.5 (P < 0.001).
The number of emergency room visits (CHF) per patient was
46% lower for program patients. The mean 6-minute walk dis-
tance did not increase signiﬁcantly from baseline (P = 0.065)
whereas there was a 10% decline in NYHA score (P < 0.001)
and a markedly improvement quality of life were registered (P <
0.001). The return on investment was calculated to be 0.82.
CONCLUSION: The evaluation demonstrates that a multidisci-
plinary heart failure program led to improved functional status
and better quality of life while at the same time reduced utiliza-
tion of acute hospital resources.
